Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Enzaplatovir is an inhibitor of Respiratory Syncytial Virus (RSV), can be used as a viral fusion protein inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Enzaplatovir is an inhibitor of Respiratory Syncytial Virus (RSV), can be used as a viral fusion protein inhibitor. |
Synonyms | BTA-585, BTA 585, BTAC585, BTA585, BTA-C585 |
Molecular Weight | 377.4 |
Formula | C20H19N5O3 |
CAS No. | 1323077-89-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Enzaplatovir 1323077-89-9 BTA-585 BTA-C 585 BTAC-585 BTA 585 BTAC 585 BTAC585 BTA585 BTA-C-585 BTA-C585 inhibitor inhibit